Tirzepatide Injections

Available Now at Nirvana Medical Spa.

Tirzepatide Injections

Available Now at Nirvana Medical Spa.

What is Tirzepatide?

Tirzepatide is injectable drug developed by Eli Lilly and Company for the treatment of diabetes (Brand Name Monjaro) . It belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. Unlike traditional diabetes treatments that target insulin resistance or insulin deficiency individually, tirzepatide combines the actions of both GLP-1 and GIP receptor agonists in a single medication.

GLP-1 receptor agonists stimulate the release of insulin, reduce appetite, and slow down the emptying of the stomach, leading to improved blood sugar control. GIP receptor agonists also increase insulin secretion and inhibit glucagon release, contributing to better glycemic control.

By combining these two mechanisms of action, tirzepatide aims to achieve robust and sustained glycemic control in individuals with type 2 diabetes. The drug is administered through a once-weekly injection, providing convenience and ease of use for patients.

"Not only have I lost over 60 pounds in 8 months, but I've also gained the freedom from all the food noise that was in my head!"

Does Tirzepatide Help With Weight Loss?

It’s important to know that Tirzepatide is not a weight loss drug.  But in studies with or without diabetes medications, weight loss ranged from 12lb to 25lb.  It’s an important mechanism of the drug, because being overweight can increase the risk of Type 2 diabetes.  It leads to insulin having a harder time working, which icreases blood sugar.

Loosing weight could help improve how your body responds to the insulin it makes and help lower blood sugar.

Lose up to 25 lbs

Possible Side Effects of Tirzepatide:

Most common side effects are nausea and constipation.  in rare occasions clients have also reported acid reflux, vomiting, stomach pain, and loose stool.  The risk of serious side effects increase in clients with hypoglycemia and abnormal kidney function.

Trizepatide should not be used with other GLP-1 medications.  This medication is not insulin and should not be used if you have been diagnosed with Type 1 Diabetes or if you develop ketoacidosis.

If you have ever been diagnosed with Pancreatitis consult your Medical provider; using Trizepatide can increase the risk of developing Pancreatitis.

If you are any family members have been diagnosed with multiple Endocrine Neoplasia Syndrome Type 2 or Medullary Thyroid cancer you should not take Tirzepatide.

To see if Trizepatide is right for you, schedule your free consultation.